Earnings Feed
Start Free
Home/Filings/4/0001209191-21-039739
4//SEC Filing

ALDRICH RICHARD 4

Accession 0001209191-21-039739

CIK 0001367920other
View on SEC.govCompany Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 8:36 AM ET

Size

15.7 KB

Accession

0001209191-21-039739

Insider Transaction Report

Form 4
Period: 2021-06-10
CONCERT PHARMACEUTICALS, INC.CNCE
ALDRICH RICHARD
Director10% Owner
Transactions
  • Award

    Common Stock

    2021-06-10+5,125→ 342,100 total
  • Award

    Stock Option (right to buy)

    2021-06-10+30,182→ 30,182 total
    Exercise: $4.26Exp: 2031-06-09→ Common Stock (30,182 underlying)
  • Award

    Stock Option (right to buy)

    2021-06-10+10,250→ 10,250 total
    Exercise: $4.26Exp: 2031-06-09→ Common Stock (10,250 underlying)
Holdings

  • Common Stock

    (indirect: By LLC)
    44,351
Footnotes (5)
  • [F1]Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. These RSUs vest in full on the earlier of (i) June 10, 2022 and (ii) the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders. The amount listed represents the maximum number of shares of Common Stock of the Issuer that may be delivered pursuant to the grant.
  • [F2]Not applicable.
  • [F3]Shares held by Little Eagles, LLC. The owners of Little Eagles, LLC are the Richard H. Aldrich Irrevocable Trust of 2011 and trusts established for the benefit of Mr. Aldrich's minor children. The trustees of the Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's spouse, Nichole A. Aldrich, and Mr. Aldrich's brother, Caleb F. Aldrich. The beneficiaries of the Richard H. Aldrich Irrevocable Trust of 2011 are Mr. Aldrich's minor children. Mr. Aldrich disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
  • [F4]The shares underlying this option vest in equal quarterly installments over a one-year period through June 10, 2022, provided that such option shall vest in full on the date that is one business day prior to the date of the Issuer's next annual meeting of stockholders (if earlier than June 10, 2022).
  • [F5]This option was granted based on Mr. Aldrich's election to receive his annual cash compensation in the form of a stock option.

Documents

2 files

Issuer

CONCERT PHARMACEUTICALS, INC.

CIK 0001367920

→
Entity typeother

Related Parties

1
  • filerCIK 0001185039

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 8:36 AM ET
Size
15.7 KB
View on SEC.gov